- You are here:
- Home
- >
- NICE quality standards
Hypertension in pregnancy
• National Institute for Health and Care Excellence •
- Women of childbearing potential with treated hypertension are given information annually about safe antihypertensive treatment during pregnancy
- Pregnant women at increased risk of pre-eclampsia at the booking appointment are offered a prescription of 75 mg of aspirin to take daily from 12 weeks until birth.
- Women with hypertension in pregnancy have a blood pressure target set below 150/100 mmHg, or, if they also have target organ damage, below 140/90 mmHg.
- Pregnant women with severe hypertension are admitted for a full assessment, carried out by a healthcare professional trained in managing hypertension in pregnancy.
- Women with a diagnosis of pre-eclampsia are admitted to hospital and monitored daily.
- Women with pre-eclampsia have an agreed consultant obstetrician-led plan for the timing and mode of birth.
- Women who have had hypertension in pregnancy have a plan for ongoing antihypertensive management included in their postnatal care plan, which is communicated to their GP when they are transferred to community care after the birth.
- Women who have had a gestational hypertension or pre-eclampsia discuss future pregnancy and lifetime cardiovascular risks during a medical review at their 6-8 week postnatal medical check.
full quality standards including quality measures avaliable from…
National Institute for Health and Care Excellence, MidCity Place
Tel – http://www.nice.org.uk/guidance/qualitystandards/qualitystandards.jsp
National Institute for Health and Care Excellence. Quality Standards Programme: Hypertension in pregnancy. July 2013